ABBVIE INC. et al v. SANDOZ INC. et al > Summary
Court Case Number 3:18-cv-12668
Filing Date Aug 10, 2018
Termination Date Oct 16, 2018
Court New Jersey District Court
Status Dismissed - Settled
JudgesFreda L. Wolfson, Lois H. Goodman
Defendant
Plaintiff Attorneys
10AbbVie Biotechnology
Attorney Name: John E. Flaherty
McCarter & English
AbbVie Inc.
Attorney Name: John E. Flaherty
McCarter & English
AbbVie Biotechnology
Attorney Name: Ravin R. Patel
McCarter & English
AbbVie Inc.
Attorney Name: Ravin R. Patel
McCarter & English
AbbVie Inc.
Attorney Name: William G. McElwain
Wilmer Cutler Pickering Hale and Dorr
AbbVie Inc.
Attorney Name: Amy K. Wigmore
Wilmer Cutler Pickering Hale and Dorr
AbbVie Inc.
Attorney Name: Michael A. Morin
Latham & Watkins
AbbVie Inc.
Attorney Name: David P. Frazier
Latham & Watkins
AbbVie Inc.
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Jonathan R. Davies
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
2Sandoz
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Sandoz
Attorney Name: Christina Saveriano
Hill Wallack LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09750808 | Formulation of human antibodies for treating TNF-alpha associated disorders | Sep 5, 2017 |
| 09187559 | Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease | Nov 17, 2015 |
